Clinical Trial Detail

NCT ID NCT01622868
Title Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

Her2-receptor positive breast cancer

Therapies

Lapatinib

Age Groups: adult senior

Additional content available in CKB BOOST